Radisens Diagnostics announced today that it has been selected as one of only six companies to partake in the recently announced National Healthcare Innovation Hub (HIH) pilot. Launched last week by the Taoiseach, Tánaiste and the Minister for Jobs, Enterprise and Innovation, the HIH will support the generation, development, validation, evaluation and implementation of new healthcare innovations. This involves the Health Service Executive (HSE) and high-tech companies collaborating to provide an effective route for new healthcare innovations from industry to access the HSE. As part of the HIH, Radisens is planning a clinical reference testing site in partnership with the HSE and local hospitals. Access to the local healthcare system will allow the company to test and validate their advanced point-of-care technology in a controlled and regulated environment ahead of commercial launch. With Ireland spending up to €1.45 billion annually on managing chronic diabetes alone, the clinical reference site will pilot the design and efficient integration of this disruptive technology, which promises huge savings for chronic disease management. About Radisens Diagnostics Based in the Rubicon Centre, Cork, Radisens Diagnostics is breaking new ground in the decentralisation of routine blood testing from central reference laboratories into GP surgeries, outpatient clinics, hospital bedsides and other point-of-care settings. With a finger-prick of blood, this diagnostic device returns laboratory-grade results within minutes during a patients GP visit. Radisens’ applications concentrate on chronic disease management – the monitoring of chronic conditions such as diabetes, heart disease, kidney and thyroid function, and cell counting, amongst others; all with a single portable analyser. With instant readout, this patented technology will remove the many anxious days or even weeks of waiting for routine blood test results, thus providing better patient care, significantly reducing healthcare costs and introducing much needed efficiencies into healthcare systems worldwide. Commercial contact: Jerry O’Brien Radisens Diagnostics Ltd E: info (at) radisens.com T: +353 21 4868190 / Fax: +353 21 4928909
